Scholars Central

Conference abstractPublished 8 Oct 2015

An underlying diagnosis of osteoarthritis is associated with better outcomes after total hip arthroplasty than avascular necrosis of bone

Authors: Jasvinder Singh

University of Alabama, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Our study objective was to examine whether Avascular Necrosis (AVN) as an underlying diagnosis was associated with a higher adjusted risk of complications and readmissions after primary Total Hip Arthroplasty (THA), compared to Osteoarthritis (OA). We analyzed prospectively collected data from a Total Joint Replacement Registry of adults with AVN vs. OA undergoing unilateral primary THA during 2001-2012. We examined mortality (90-day), revision (ever), deep (1 year) and superficial (30-day) Surgical Site Infection (SSI), venous thromboembolism (VTE, 90-day), and unplanned readmission (90-day). Age, gender, race, body mass index, American Society of Anesthesiologists class, and diabetes prevalence were evaluated as confounders. Logistic and Cox regression models were fit with variables significant in univariate models for each outcome. Odds Ratios (OR) and hazard ratios with 95% Confidence Intervals (CI) were calculated. Of the 47,523 primary THA cases, 45,252 (95.2%) had OA, and 2,271 (4.8%) had AVN. Compared to the OA cohort, the AVN patient cohort was younger (55 vs. 67 years), more male (57.5% vs. 41.7%), and less White (59.8% vs. 77.4%). Compared to the OA cohort, the AVN cohort had higher crude incidence of 90-day mortality (0.7% vs. 0.3%), revision (3.1% vs. 2.4%), SSI (1.2% vs. 0.8%), and unplanned readmission (9.6% vs. 5.2%). After multivariable-adjustment for significant factors, AVN patients had a higher likelihood of mortality (OR:2.48; 95% CI:1.31-4.72), SSI (OR:1.67, 95%CI:1.11-2.51), and unplanned readmissions (OR:2.20; 95% CI:1.67-2.91) than OA patients. Detailed discussion with AVN patients regarding the risk of complications is needed during the informed consent.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Pharmaceutical Care & Health Systems.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutical Care & Health Systems
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Jasvinder Singh”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels